Abstract: Provided is a composite membrane for western blot, in which the composite membrane is prepared by combining nanofiber webs with nonwoven fabrics, and a basis weight of the nanofibers is in a range of 1 gsm to 50 gsm on the nonwoven fabrics, and an average pore size is in a range of 0.1 ?m to 1.0 ?m. The composite membrane for western blot including nanofibers has advantages such as saving of a production cost, and an excellent response characteristic due to a capillary phenomenon of a double structure, to thereby easily detect even a small amount of a particular substance present in a protein.

Abstract: Provided is a 2-(substituted ethynyl)quinoline derivative having an mGluR5 antagonistic activity and pharmaceutically acceptable salts thereof. The compound of the present invention can be useful as a medicament for treating and preventing mGluR5 receptor-mediated diseases such as Alzheimer's disease, senile dementia, Parkinson's disease, L-DOPA-induced dyskinesia, Huntington's chorea, amyotrophic lateral sclerosis, multiple sclerosis, schizophrenia, anxiety disorder, depression, neuropathic pain, drug dependence, fragile X syndrome, autism, migraine and gastroesophageal reflux disease (GERD).

Abstract: Disclosed is a prediction method for monitoring performance of power plant instruments. The prediction method extracts a principal component of an instrument signal, obtains an optimized constant of a SVR model through a response surface methodology using data for optimization, and trains a model using training data. Therefore, compared to an existing Kernel regression method, accuracy for calculating a prediction value can be improved.

Abstract: Provided is a metal card including a metal card sheet made of duralumin and an anodized layer formed by anodizing a surface of the metal card sheet, wherein a background color or pattern of the metal card is determined according to a composition of electrolyte of the anodizing for forming the anodized layer.

Abstract: Provided are a benzimidazole derivative modulating mitochondrial functions and having pharmaceutical activity as a neuro-protective agent, and a pharmaceutical composition including the compound as an active ingredient.

Abstract: A hologram data processing method using a hologram fringe data format adaptive to a data encoding scheme includes configuring model data of a three-dimensional (3D) object corresponding to source data to be used for generating a hologram, computing hologram fringe data by applying a diffraction transform to a light wave transferred to a hologram plane based on the model data of the 3D object, setting, in the computed hologram fringe data, the hologram fringe data format adaptive to a data encoding scheme for reconstructing the hologram, reconstructing an optical hologram by applying the data encoding scheme to the hologram fringe data, and adjusting the optical hologram by comparing a reconstructed image of the optical hologram to a reconstructed image of a numerical hologram.

Abstract: A robotic sunlight tracking apparatus reduces power consumption and improves efficiency of solar photovoltaic power generation. The apparatus includes a solar cell module for converting sunlight into electricity, a rotation shaft connected to a backside of the solar cell module for supporting the solar cell module while rotating, a cylindrical body under the rotation shaft having a cam with a curvature formed as a recess in a surface of the cylindrical body and a motor built therein to rotate in one direction by operation of a timer, and fixing means for fixing the cylindrical body to ground. The rotation shaft includes a cam follower at one side of the cylindrical body placed in the cam for moving following the cam as the motor rotates, and a lift arm connected to the cam follower for moving up/down, adjusting an angle of the solar cell module when the cam follower moves.

Abstract: A porous polymer web layer of ultrafine fibers, and a non-porous film layer made of a material that is swellable and allows conduction of electrolyte ions in an electrolyte solution, are integrally provided on one surface or both surfaces of a positive electrode or a negative electrode, and a short circuit between the positive electrode and the negative electrode by the inorganic particles contained in polymer web is prevented although a battery is overheated. The electrode assembly includes: a positive electrode; a negative electrode; and a separator that separates the positive electrode and the negative electrode. The separator comprises: a first non-porous polymer film layer; and a porous polymer web layer that is formed on the first non-porous polymer film layer and is made of ultrafine fibers of a mixture of a heat-resistant polymer and inorganic particles or a mixture of a heat-resistant polymer, a swellable polymer, and inorganic particles.

Abstract: The present invention relates to a membrane for Western blotting which has a three-dimensional open pore structure, an average pore diameter of 0.1-1.0 ?m and a thickness of 30-200 ?m, wherein the membrane for Western blotting is manufactured by subjecting nanofibers having an average fiber diameter of 50-1000 nm, obtained by electrospinning, to a hot-plate calendering process, and a method for manufacturing the same. The method comprises the steps of: dissolving a hydrophobic material in a solvent to prepare a spinning solution; subjecting the spinning solution to a spinning process to obtain a hydrophobic polymer nanofiber web; and calendering the obtained nanofiber web to obtain a membrane for Western blotting.

Abstract: The present invention relates to a method for preparing tetrabenazine (TBZ) and dihydrotetrabenazine (DTBZ), and more specifically to a method for preparing tetrabenazine (TBZ) and dihydrotetrabenazine (DTBZ) by using simple and short reaction processes of using 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline and 4-methyl-2-(3-(trimethylsilyl)prop-1-ene-2-yl)pentane as starting materials to sequentially perform an alkylation reaction, an Aza-Prins cyclization reaction in the presence of an oxidant and an oxidation reaction.

Abstract: Disclosed are novel imidazolylalkylcarbonyl derivatives useful as calcium channel modulators and a preparation method of the same. Also disclosed is a method for the treatment of diseases by administering the above compounds based on their inhibitory activity against calcium channel.

Abstract: There are provided an autostereoscopic 3-Dimensional (3D) display apparatus and a display method thereof. In the autostereoscopic 3D display apparatus, a 3D display is disposed in a standing position, and a reflection structure reflects light emitted from the screen of the 3D display to provide a 3D image in a 3D space. Accordingly, a deflection of the 3D display is reduced so that a 3D image pattern having no distortion is formed.

Abstract: Provided is a paper shredder. The paper shredder includes a paper support part including a first paper support part having a first length, a second paper support part having a second length greater than the first length, and a paper feed slot between the first paper support part and the second paper support part, a first roller in which a portion thereof is exposed upward from the second paper support part through an opening defined in the second paper support part, a second roller in which a portion thereof is exposed upward from the first paper support part through an opening defined in the first paper support part, a cutter disposed below the paper feed slot to shred an introduced paper, and a motor operating the first roller, the second roller, and the cutter. The first paper support part and the second paper support part are reduced in height as being adjacent to the paper feed slot.

Abstract: The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder.

Abstract: The present invention relates to pyrazolylmethylamine-piperazine derivatives and their pharmaceutically acceptable salts effective as calcium channel modulators and a method of manufacturing the same. The present invention also relates to the medicinal use of the above compounds as therapeutic treatment of diseases due to their effect as calcium channel modulators.

Abstract: Provided are a switching circuit and a small-size high-efficiency direct current-to-direct current (DC-DC) converter for portable devices including the same. Using dynamic threshold-complementary metal oxide semiconductor (DT-CMOS) transistors having dynamic threshold voltages as a switching device, the switching circuit maintains a low threshold voltage in a normal mode to improve current drivability while reducing conduction loss, and maintains a high threshold voltage in a standby mode to minimize power consumption. When the switching circuit is employed in a DC-DC converter, power conversion efficiency can be improved by reducing conduction loss in the normal mode, and power consumption can be minimized in the standby mode. Consequently, the DC-DC converter can maximize a use time of a battery of a portable device and can be useful in power supplies of portable devices that are gradually being miniaturized.

Abstract: Provided is an ultrafine fibrous porous separator with heat resistance and high-strength and a manufacturing method thereof, which enables mass-production of a heat-resistant and high-strength ultrafine fibrous separator by using an air-electrospinning (AES) method, and to a secondary battery using the same. The method of manufacturing a heat-resistant and high-strength ultrafine fibrous porous separator includes the steps of: air-electrospinning a mixed solution of 50 to 70 wt % of a heat-resistant, polymer material and 30 to 50 wt % of a swelling polymer material, to thereby form a porous web of a heat-resistant ultrafine fiber in which the heat-resistant polymer material and the swelling polymer material are consolidated in an ultrafine fibrous form; performing drying to control a solvent and moisture that remain on the surface of the porous web; and performing thermal compression on the dried porous web at a temperature of between 170° C. and 210° C. so as to obtain the separator.

Abstract: The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder.

Abstract: The present invention relates to a novel piperazinyl-propyl-pyrazole derivative, a method of its preparation and a pharmaceutically acceptable composition comprising the same. The novel piperazinyl-propyl-pyrazole derivative of the present invention has superior selective affinity for dopamine D4 receptor, can effectively inhibit psychotic behavior (cage climbing) induced by apomorphine, and has relatively low adverse effects in mouse rotarod test. Therefore, it can be developed as a therapeutic agent for the treatment and prevention of central nervous system (CNS) disorders, in particular, schizophrenia, attention deficit hyperactivity disorder, depression, stress diseases, panic disorder, phobia, obsessive-compulsive disorder, posttraumatic stress disorder, cognitive disorder, Alzheimer's disease, Parkinson's disease, anxiety, paraphrenia, mania, seizure disorder, personality disorder, migraine, drug addiction, alcohol addiction, obesity, eating disorder, and sleeping disorder.

Abstract: The present invention relates to a novel medicinal use of pyrazolopyrimidine compounds having superior effect as serotonin 5-HT2C receptor ligand thus being useful for the prevention and treatment of central nervous system (CNS) diseases. Accordingly, the pharmaceutical composition comprising pyrazolopyrimidine compounds and their pharmaceutically acceptable salts as active ingredients are useful for the prevention and treatment of serotonin 5-HT2C-related central nervous system diseases such as obesity, depression, anxiety and withdrawal symptoms due to drug abuse.